- Multi-pathway metabolic support
- Appetite control, fat loss, blood sugar balance
- Activates GLP-1, GIP, glucagon receptors → powerful fat loss signaling
- Slows gastric emptying → longer satiety, reduced cravings
West Kelowna, British Columbia
West Kelowna, British Columbia
Pricing available to research clients
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors. Research shows strong interest in appetite control, earlier satiety, body-weight and waist reduction, glucose and insulin regulation, energy expenditure, liver-fat reduction, and broader cardiometabolic improvements.